| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | ZNF620 ZNF12 ZKSCAN7 ZNF555 NRF1 ZNF544 LEF1 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 2.96e-07 | 1412 | 40 | 14 | GO:0000981 |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | ZNF620 ZNF12 ZKSCAN7 ZNF555 NRF1 ZNF544 LEF1 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 4.42e-07 | 1459 | 40 | 14 | GO:0000977 |
| GeneOntologyMolecularFunction | benzodiazepine receptor activity | 2.13e-04 | 11 | 40 | 2 | GO:0008503 | |
| GeneOntologyMolecularFunction | GABA-gated chloride ion channel activity | 5.87e-04 | 18 | 40 | 2 | GO:0022851 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 6.47e-04 | 1244 | 40 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | GABA-A receptor activity | 6.55e-04 | 19 | 40 | 2 | GO:0004890 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 7.56e-04 | 1271 | 40 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | GABA receptor activity | 8.81e-04 | 22 | 40 | 2 | GO:0016917 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potential | 1.05e-03 | 24 | 40 | 2 | GO:0099507 | |
| GeneOntologyCellularComponent | GABA-A receptor complex | 5.68e-04 | 19 | 39 | 2 | GO:1902711 | |
| GeneOntologyCellularComponent | GABA receptor complex | 6.96e-04 | 21 | 39 | 2 | GO:1902710 | |
| Domain | zf-C2H2 | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 6.91e-09 | 693 | 38 | 12 | PF00096 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 2.40e-08 | 775 | 38 | 12 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 2.47e-08 | 777 | 38 | 12 | PS00028 |
| Domain | Znf_C2H2-like | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 3.22e-08 | 796 | 38 | 12 | IPR015880 |
| Domain | Znf_C2H2 | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 3.64e-08 | 805 | 38 | 12 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 3.80e-08 | 808 | 38 | 12 | SM00355 |
| Domain | - | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 6.64e-08 | 679 | 38 | 11 | 3.30.160.60 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 8.29e-08 | 694 | 38 | 11 | IPR013087 |
| Domain | KRAB | 4.99e-07 | 358 | 38 | 8 | PS50805 | |
| Domain | KRAB | 4.99e-07 | 358 | 38 | 8 | PF01352 | |
| Domain | KRAB | 6.27e-07 | 369 | 38 | 8 | SM00349 | |
| Domain | KRAB | 6.40e-07 | 370 | 38 | 8 | IPR001909 | |
| Domain | zf-C2H2_6 | 2.86e-06 | 314 | 38 | 7 | PF13912 | |
| Domain | GABAAa_rcpt | 6.02e-05 | 6 | 38 | 2 | IPR001390 | |
| Domain | GABAA/Glycine_rcpt | 9.93e-04 | 23 | 38 | 2 | IPR006028 | |
| Domain | Neurotransmitter_ion_chnl_CS | 3.78e-03 | 45 | 38 | 2 | IPR018000 | |
| Domain | Neur_chan_memb | 3.94e-03 | 46 | 38 | 2 | PF02932 | |
| Domain | Neur_chan_LBD | 4.11e-03 | 47 | 38 | 2 | PF02931 | |
| Domain | Neur_channel | 4.11e-03 | 47 | 38 | 2 | IPR006201 | |
| Domain | Neur_chan_lig-bd | 4.11e-03 | 47 | 38 | 2 | IPR006202 | |
| Domain | NEUROTR_ION_CHANNEL | 4.11e-03 | 47 | 38 | 2 | PS00236 | |
| Domain | Neurotrans-gated_channel_TM | 4.11e-03 | 47 | 38 | 2 | IPR006029 | |
| Domain | - | 4.11e-03 | 47 | 38 | 2 | 2.70.170.10 | |
| Pathway | BIOCARTA_FLUMAZENIL_PATHWAY | 1.26e-04 | 9 | 27 | 2 | M22034 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.57e-04 | 10 | 27 | 2 | MM1401 | |
| Pathway | BIOCARTA_GABA_PATHWAY | 1.57e-04 | 10 | 27 | 2 | M477 | |
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 9655866 | ||
| Pubmed | 1.29e-06 | 2 | 40 | 2 | 23744069 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 29023704 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 16835366 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 1356407 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 34433078 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15017002 | ||
| Pubmed | 3.87e-06 | 3 | 40 | 2 | 15304513 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 25865415 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 26518133 | ||
| Pubmed | 7.73e-06 | 4 | 40 | 2 | 25080596 | ||
| Pubmed | Altered GABA(A) receptor subunit expression and pharmacology in human Angelman syndrome cortex. | 7.73e-06 | 4 | 40 | 2 | 20692323 | |
| Pubmed | GABA(A) receptor downregulation in brains of subjects with autism. | 7.73e-06 | 4 | 40 | 2 | 18821008 | |
| Pubmed | Itch suppression in mice and dogs by modulation of spinal α2 and α3GABAA receptors. | 1.29e-05 | 5 | 40 | 2 | 30104684 | |
| Pubmed | 1.93e-05 | 6 | 40 | 2 | 20457185 | ||
| Pubmed | Modelling extracellular domains of GABA-A receptors: subtypes 1, 2, 3, and 5. | 1.93e-05 | 6 | 40 | 2 | 15033447 | |
| Pubmed | Attack behaviors in mice: from factorial structure to quantitative trait loci mapping. | 1.93e-05 | 6 | 40 | 2 | 16266699 | |
| Pubmed | Lamina-specific alterations in cortical GABA(A) receptor subunit expression in schizophrenia. | 2.70e-05 | 7 | 40 | 2 | 20843900 | |
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 35228700 | ||
| Pubmed | 2.70e-05 | 7 | 40 | 2 | 16101898 | ||
| Pubmed | 2.82e-05 | 51 | 40 | 3 | 20351714 | ||
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 8175718 | ||
| Pubmed | Histone H2AX-dependent GABA(A) receptor regulation of stem cell proliferation. | 3.60e-05 | 8 | 40 | 2 | 18185516 | |
| Pubmed | 3.60e-05 | 8 | 40 | 2 | 11528422 | ||
| Pubmed | 5.77e-05 | 10 | 40 | 2 | 36733270 | ||
| Pubmed | Functional modifications of acid-sensing ion channels by ligand-gated chloride channels. | 5.77e-05 | 10 | 40 | 2 | 21789198 | |
| Pubmed | Review: Central non-glucocorticoid inhibitors of the hypothalamo-pituitary-adrenal axis. | 7.05e-05 | 11 | 40 | 2 | 9924185 | |
| Pubmed | Region and layer-specific expression of GABAA receptor isoforms and KCC2 in developing cortex. | 7.05e-05 | 11 | 40 | 2 | 38894703 | |
| Pubmed | Chromosomal localization of GABAA receptor subunit genes: relationship to human genetic disease. | 8.45e-05 | 12 | 40 | 2 | 2561974 | |
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 22640814 | ||
| Pubmed | 9.98e-05 | 13 | 40 | 2 | 22569571 | ||
| Pubmed | 1.13e-04 | 81 | 40 | 3 | 22723691 | ||
| Pubmed | 1.16e-04 | 14 | 40 | 2 | 22768092 | ||
| Pubmed | Zfp423/OAZ participates in a developmental switch during olfactory neurogenesis. | 1.53e-04 | 16 | 40 | 2 | 17521568 | |
| Pubmed | The protomap is propagated to cortical plate neurons through an Eomes-dependent intermediate map. | 1.76e-04 | 94 | 40 | 3 | 23431145 | |
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 18985723 | ||
| Pubmed | 1.95e-04 | 18 | 40 | 2 | 19078961 | ||
| Pubmed | 2.67e-04 | 21 | 40 | 2 | 25708312 | ||
| Pubmed | 2.94e-04 | 22 | 40 | 2 | 35245678 | ||
| Pubmed | Chromosomal localization of the genes for five zinc finger proteins expressed in mouse lens. | 2.94e-04 | 22 | 40 | 2 | 7590745 | |
| Pubmed | 3.50e-04 | 24 | 40 | 2 | 9606417 | ||
| Pubmed | Genome-wide association analysis of metabolic traits in a birth cohort from a founder population. | 4.12e-04 | 26 | 40 | 2 | 19060910 | |
| Pubmed | 7.07e-04 | 34 | 40 | 2 | 24026423 | ||
| Pubmed | 7.93e-04 | 36 | 40 | 2 | 27736991 | ||
| Interaction | ZNF473 interactions | 8.43e-08 | 56 | 40 | 5 | int:ZNF473 | |
| Interaction | ZNF710 interactions | 3.51e-07 | 30 | 40 | 4 | int:ZNF710 | |
| Interaction | ZFP3 interactions | 3.51e-07 | 30 | 40 | 4 | int:ZFP3 | |
| Interaction | ZNF382 interactions | 5.22e-07 | 33 | 40 | 4 | int:ZNF382 | |
| Interaction | RBAK interactions | 5.45e-07 | 81 | 40 | 5 | int:RBAK | |
| Interaction | ZNF513 interactions | 5.91e-07 | 34 | 40 | 4 | int:ZNF513 | |
| Interaction | ZNF652 interactions | 6.66e-07 | 35 | 40 | 4 | int:ZNF652 | |
| Interaction | ZFP28 interactions | 8.38e-07 | 37 | 40 | 4 | int:ZFP28 | |
| Interaction | ZFP37 interactions | 2.64e-06 | 49 | 40 | 4 | int:ZFP37 | |
| Interaction | ZNF667 interactions | 3.63e-06 | 53 | 40 | 4 | int:ZNF667 | |
| Interaction | ZSCAN21 interactions | 5.26e-06 | 128 | 40 | 5 | int:ZSCAN21 | |
| Interaction | ZNF287 interactions | 5.99e-06 | 60 | 40 | 4 | int:ZNF287 | |
| Interaction | CTCFL interactions | 6.83e-06 | 62 | 40 | 4 | int:CTCFL | |
| Interaction | ZNF787 interactions | 7.76e-06 | 64 | 40 | 4 | int:ZNF787 | |
| Interaction | ZNF423 interactions | 1.31e-05 | 73 | 40 | 4 | int:ZNF423 | |
| Interaction | PRDM5 interactions | 1.89e-05 | 80 | 40 | 4 | int:PRDM5 | |
| Interaction | MYNN interactions | 3.45e-05 | 32 | 40 | 3 | int:MYNN | |
| Interaction | GABRA5 interactions | 3.83e-05 | 5 | 40 | 2 | int:GABRA5 | |
| Interaction | GLI3 interactions | 4.20e-05 | 98 | 40 | 4 | int:GLI3 | |
| Interaction | ZFP62 interactions | 4.37e-05 | 99 | 40 | 4 | int:ZFP62 | |
| Interaction | PRDM4 interactions | 1.50e-04 | 52 | 40 | 3 | int:PRDM4 | |
| Interaction | ZNF768 interactions | 2.24e-04 | 151 | 40 | 4 | int:ZNF768 | |
| Interaction | ZBTB48 interactions | 2.67e-04 | 158 | 40 | 4 | int:ZBTB48 | |
| Interaction | ZNF8 interactions | 3.62e-04 | 70 | 40 | 3 | int:ZNF8 | |
| Interaction | ZNF24 interactions | 3.85e-04 | 174 | 40 | 4 | int:ZNF24 | |
| Interaction | ZBTB17 interactions | 4.79e-04 | 77 | 40 | 3 | int:ZBTB17 | |
| Interaction | LTBP2 interactions | 6.39e-04 | 85 | 40 | 3 | int:LTBP2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 5.24e-06 | 797 | 40 | 7 | chr19p13 | |
| Cytoband | 7p22.1 | 7.81e-04 | 47 | 40 | 2 | 7p22.1 | |
| Cytoband | 19p13.2 | 1.06e-03 | 229 | 40 | 3 | 19p13.2 | |
| Cytoband | 12q24.31 | 2.24e-03 | 80 | 40 | 2 | 12q24.31 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 6.13e-03 | 134 | 40 | 2 | chr7p22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF620 ZNF12 ZKSCAN7 ZNF555 ZNF544 CASZ1 ZNF423 ZFP37 ZFP62 RBAK ZNF121 ZNF557 | 3.92e-10 | 718 | 29 | 12 | 28 |
| GeneFamily | Gamma-aminobutyric acid type A receptor subunits | 4.18e-04 | 19 | 29 | 2 | 563 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | KIAA1549L PDE10A LEF1 GIN1 ZNF423 ZFP37 FAT3 KIF11 GABRA1 GABRA3 | 7.13e-06 | 1060 | 36 | 10 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| ToppCell | E15.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.63e-07 | 154 | 40 | 5 | e65e4636646164610f33f7bbac0d879a3ea55986 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.52e-07 | 185 | 40 | 5 | 60206c7322b4ddb2010040aac70561df842c9843 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.44e-07 | 190 | 40 | 5 | e83fa8b711aa79a1767818474f1c193b674b1c31 | |
| ToppCell | Adult-Endothelial-capillary_endothelial_cell_(Cap1)-D231|Adult / Lineage, Cell type, age group and donor | 2.25e-05 | 185 | 40 | 4 | 07f9f38f0739d7c830641723a38385550ac1ac92 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | efcfbf5a48b3ea9a425183e5c2eec6a9585415a0 | |
| ToppCell | droplet-Liver-Hepatocytes-21m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.25e-05 | 185 | 40 | 4 | 642088ace9230d38b0579853c54ff4dd8b5d5df4 | |
| ToppCell | Control-Endothelial-Endothelial-Vein|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.30e-05 | 186 | 40 | 4 | 92092f11ecce22c14f244e42c499af0822977e6f | |
| ToppCell | COVID-19-Endothelial_cells-Pulmonary_venous_endothelial_cells|COVID-19 / group, cell type (main and fine annotations) | 2.35e-05 | 187 | 40 | 4 | 2d20193a6cacdfa4877457c97b0077408942186c | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 2.45e-05 | 189 | 40 | 4 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_pulmonary_venous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.00e-05 | 199 | 40 | 4 | 3a4deea6e11a0555d27497b7c9983350797aac69 | |
| ToppCell | Sepsis-Bac-SEP-Lymphocyte-T/NK-NK_CD56bright|Bac-SEP / Disease, condition lineage and cell class | 3.05e-05 | 200 | 40 | 4 | ebab762fe5209c23c5a9ac9281f728fafa433af3 | |
| Drug | Zolpidem | 9.02e-06 | 3 | 40 | 2 | DB00425 | |
| Drug | Flumazenil | 1.80e-05 | 4 | 40 | 2 | DB01205 | |
| Drug | Eszopiclone | 3.00e-05 | 5 | 40 | 2 | DB00402 | |
| Drug | Zopiclone | 3.00e-05 | 5 | 40 | 2 | DB01198 | |
| Drug | Lorazepam | 3.00e-05 | 5 | 40 | 2 | ctd:D008140 | |
| Drug | DMCM | 4.06e-05 | 38 | 40 | 3 | CID000104999 | |
| Drug | Meprobamate | 4.49e-05 | 6 | 40 | 2 | DB00371 | |
| Drug | Quazepam | 6.28e-05 | 7 | 40 | 2 | DB01589 | |
| Drug | Adinazolam | 8.37e-05 | 8 | 40 | 2 | DB00546 | |
| Drug | Fludiazepam | 8.37e-05 | 8 | 40 | 2 | DB01567 | |
| Drug | Clotiazepam | 8.37e-05 | 8 | 40 | 2 | DB01559 | |
| Drug | Cinolazepam | 8.37e-05 | 8 | 40 | 2 | DB01594 | |
| Drug | Prazepam | 8.37e-05 | 8 | 40 | 2 | DB01588 | |
| Drug | Estazolam | 8.37e-05 | 8 | 40 | 2 | DB01215 | |
| Drug | Halazepam | 8.37e-05 | 8 | 40 | 2 | DB00801 | |
| Drug | 1-(4-ethynylphenyl)-4-propyl-2,6,7-trioxabicyclo(2.2.2)octane | 8.37e-05 | 8 | 40 | 2 | ctd:C091518 | |
| Drug | tiotidine | 1.08e-04 | 9 | 40 | 2 | ctd:C023990 | |
| Drug | Ethchlorvynol | 1.08e-04 | 9 | 40 | 2 | DB00189 | |
| Drug | AC1L18T4 | 1.08e-04 | 9 | 40 | 2 | CID000000246 | |
| Drug | Diazepam | 1.08e-04 | 9 | 40 | 2 | DB00829 | |
| Drug | Secobarbital | 1.34e-04 | 10 | 40 | 2 | DB00418 | |
| Drug | Chlordiazepoxide | 1.34e-04 | 10 | 40 | 2 | DB00475 | |
| Drug | Metharbital | 1.34e-04 | 10 | 40 | 2 | DB00463 | |
| Drug | Pentobarbital | 1.34e-04 | 10 | 40 | 2 | DB00312 | |
| Drug | Talbutal | 1.34e-04 | 10 | 40 | 2 | DB00306 | |
| Drug | Clobazam | 1.34e-04 | 10 | 40 | 2 | DB00349 | |
| Drug | Butalbital | 1.34e-04 | 10 | 40 | 2 | DB00241 | |
| Drug | Butabarbital | 1.34e-04 | 10 | 40 | 2 | DB00237 | |
| Drug | Bromazepam | 1.34e-04 | 10 | 40 | 2 | DB01558 | |
| Drug | Barbituric acid derivative | 1.34e-04 | 10 | 40 | 2 | DB01496 | |
| Drug | Barbital | 1.34e-04 | 10 | 40 | 2 | DB01483 | |
| Drug | Hexobarbital | 1.34e-04 | 10 | 40 | 2 | DB01355 | |
| Drug | Aprobarbital | 1.34e-04 | 10 | 40 | 2 | DB01352 | |
| Drug | Amobarbital | 1.34e-04 | 10 | 40 | 2 | DB01351 | |
| Drug | Heptabarbital | 1.34e-04 | 10 | 40 | 2 | DB01354 | |
| Drug | Butethal | 1.34e-04 | 10 | 40 | 2 | DB01353 | |
| Drug | Clonazepam | 1.34e-04 | 10 | 40 | 2 | DB01068 | |
| Drug | Methylphenobarbital | 1.34e-04 | 10 | 40 | 2 | DB00849 | |
| Drug | Oxazepam | 1.34e-04 | 10 | 40 | 2 | DB00842 | |
| Drug | Primidone | 1.34e-04 | 10 | 40 | 2 | DB00794 | |
| Drug | Midazolam | 1.34e-04 | 10 | 40 | 2 | DB00683 | |
| Drug | Flurazepam | 1.34e-04 | 10 | 40 | 2 | DB00690 | |
| Drug | Thiopental | 1.64e-04 | 11 | 40 | 2 | DB00599 | |
| Drug | Alprazolam | 1.64e-04 | 11 | 40 | 2 | DB00404 | |
| Drug | Temazepam | 1.64e-04 | 11 | 40 | 2 | DB00231 | |
| Drug | Nitrazepam | 1.64e-04 | 11 | 40 | 2 | DB01595 | |
| Drug | Lorazepam | 1.64e-04 | 11 | 40 | 2 | DB00186 | |
| Drug | Phenobarbital | 1.64e-04 | 11 | 40 | 2 | DB01174 | |
| Drug | Triazolam | 1.64e-04 | 11 | 40 | 2 | DB00897 | |
| Drug | Clorazepate | 1.64e-04 | 11 | 40 | 2 | DB00628 | |
| Drug | Ciclopirox ethanolamine [41621-49-2]; Up 200; 15uM; HL60; HT_HG-U133A | 2.43e-04 | 174 | 40 | 4 | 2456_UP | |
| Drug | methylclofenapate | 3.56e-04 | 16 | 40 | 2 | CID000030602 | |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 3.75e-04 | 195 | 40 | 4 | 1138_DN | |
| Drug | Delcorine; Down 200; 8.4uM; PC3; HT_HG-U133A | 3.75e-04 | 195 | 40 | 4 | 3715_DN | |
| Drug | Trapidil [15421-84-8]; Down 200; 19.4uM; HL60; HT_HG-U133A | 3.82e-04 | 196 | 40 | 4 | 3136_DN | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 3.89e-04 | 197 | 40 | 4 | 5242_UP | |
| Drug | LY 294002; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 6976_UP | |
| Drug | Scopolamine hydrochloride [55-16-3]; Up 200; 11.8uM; HL60; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 3018_UP | |
| Drug | SB 203580; Down 200; 1uM; PC3; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 7066_DN | |
| Drug | Felbinac [5728-52-9]; Down 200; 18.8uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 3398_DN | |
| Drug | Griseofulvin [126-07-8]; Down 200; 11.2uM; PC3; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 7363_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 3.97e-04 | 198 | 40 | 4 | 3970_UP | |
| Drug | SR 27897 | 4.03e-04 | 17 | 40 | 2 | CID000122077 | |
| Drug | dihydroxyaflavinine | 4.03e-04 | 17 | 40 | 2 | CID000156857 | |
| Drug | Gelsemine [509-15-9]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 4.05e-04 | 199 | 40 | 4 | 4177_UP | |
| Disease | 4-ethylphenylsulfate measurement | 1.59e-06 | 18 | 38 | 3 | EFO_0021148 | |
| Disease | primary aldosteronism | 5.15e-04 | 26 | 38 | 2 | MONDO_0001422 | |
| Disease | Hepatic fibrosis | 1.83e-03 | 49 | 38 | 2 | HP_0001395 | |
| Disease | Crohn Disease | 1.90e-03 | 50 | 38 | 2 | C0010346 | |
| Disease | obesity (implicated_via_orthology) | 2.67e-03 | 215 | 38 | 3 | DOID:9970 (implicated_via_orthology) | |
| Disease | sarcoidosis | 3.10e-03 | 64 | 38 | 2 | MONDO_0019338 | |
| Disease | Bipolar Disorder | 3.22e-03 | 477 | 38 | 4 | C0005586 | |
| Disease | Alcohol abuse | 3.39e-03 | 67 | 38 | 2 | C0085762 | |
| Disease | Antihypertensive use measurement | 4.79e-03 | 265 | 38 | 3 | EFO_0009927 | |
| Disease | Alcoholic Intoxication, Chronic | 4.94e-03 | 268 | 38 | 3 | C0001973 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TYARTHTHSVFMSSN | 11 | Q6ZS92 | |
| VYTSTSDVMTHENFH | 561 | Q86V15 | |
| TSYAIAMHFHLSTSQ | 541 | P43155 | |
| ASLSRFSYSHMSASV | 411 | P32238 | |
| RHFGSSDTFSTHMSL | 1826 | Q9Y485 | |
| MASSEFHSDHRLSYS | 16 | Q9UKP5 | |
| VTHISFSHDSQYMAT | 696 | Q8TBY9 | |
| SSLSVDTSMSRFSHH | 231 | Q9UJU2 | |
| TLMNAYSSRSHSVFS | 226 | P52732 | |
| YSSRSHSVFSVTIHM | 231 | P52732 | |
| SFSVFRPSSYHIMVS | 481 | Q02817 | |
| YSTSTMEQHHFSQTV | 576 | Q9Y233 | |
| QVHVATYTEHSMLSA | 26 | Q16656 | |
| RSSTGEYVVMTTHFH | 256 | P34903 | |
| QSSTGEYVVMTTHFH | 231 | P14867 | |
| PTYMYARTGHTTSTH | 711 | Q6ZVL6 | |
| STCVSHLTVVVMHYS | 241 | O60404 | |
| HYSKSDTQTHTMFLA | 606 | Q9H0J9 | |
| TQMLTHRSSDGTYHT | 171 | Q6ZMU1 | |
| SHFSLSLRGYSSHMT | 291 | Q9BT40 | |
| SHALMTYSTARISFV | 3761 | Q8TDW7 | |
| YASSMVTSSSILDHF | 306 | A6NGH7 | |
| RSYFSHGMISSHITE | 266 | Q5TEA3 | |
| HSDYSMTLSVRVHTW | 711 | O00462 | |
| ESSTKFRHHMYTNVS | 231 | Q9H4B8 | |
| SHHYVSTFLSGVMLT | 191 | A0PK00 | |
| FHTSNRSHVYAIIMT | 151 | Q9NXP7 | |
| HNSHTSATASVMYTV | 266 | O14581 | |
| RVHSHSAVYASSMSP | 391 | Q9NUV7 | |
| RVTIIHSHSSFSAMA | 121 | P37287 | |
| FSYSSAFRRHMITHT | 321 | Q8NEP9 | |
| VFSRMSNLTVHYRSH | 631 | Q9NYW8 | |
| TFSCSSSFTVHQRMH | 316 | Q6ZNG0 | |
| TYSTSHAVSVKMHTV | 126 | P58317 | |
| FARSSYLVMHQRTHT | 641 | Q6NX49 | |
| YMSYSSLINHKSTHS | 206 | Q8NB50 | |
| VFSYSSSLMVHQRTH | 671 | Q9P0L1 | |
| AFSRMSYLTVHYRTH | 641 | P17014 | |
| LTVHYMTTSTHYVCE | 681 | Q2M1K9 | |
| FTSNSYLSVHTRMHN | 406 | Q8N988 | |
| SSSLTYHMRTHTGES | 501 | Q9Y6Q3 | |
| YETASLMSQVSHTHL | 656 | P29597 |